News | March 13, 2023
Zydus receives final approval from the USFDA for Olanzapine
Olanzapine Orally Disintegrating Tablets are used to treat certain mental/mood conditions
Olanzapine Orally Disintegrating Tablets are used to treat certain mental/mood conditions
Erythromycin Tablets USP, 250 mg and 500 mg are used to prevent and treat infections in many different parts of the body
Ashland’s pharmaceutical business is well known for acetylenics, cellulosics, and film coatings
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
Smart-performance, fully biodegradable biopolymer sourced from renewable raw materials
Julie is recognized as a highly engaging multi-cultural leader skilled in fluidly partnering with cross-functional teams to deliver results.
Vigabatrin for Oral Solution USP, 500 mg had annual sales of US $233.7 mn in US
Vigabatrin for Oral Solution USP, 500 mg had annual sales of USD 233.7 mn in the United States
he product will be launched shortly in the US market.
Apixaban Tablets, 2.5 mg and 5 mg had annual sales of USD 18,876 mn in the United States (IQVIA MAT Dec. 2022).
Subscribe To Our Newsletter & Stay Updated
